Randomized dose-escalation designs for drug combination cancer trials with immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized dose-escalation designs for drug combination cancer trials with immunotherapy
Authors
Keywords
-
Journal
Journal of Biopharmaceutical Statistics
Volume -, Issue -, Pages 1-19
Publisher
Informa UK Limited
Online
2018-10-25
DOI
10.1080/10543406.2018.1535503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
- (2017) Brigitte Dréno et al. LANCET ONCOLOGY
- Precision medicine needs randomized clinical trials
- (2017) Everardo D. Saad et al. Nature Reviews Clinical Oncology
- Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors
- (2016) Noboru Yamamoto et al. INVESTIGATIONAL NEW DRUGS
- Dimension of model parameter space and operating characteristics in adaptive dose-finding studies
- (2016) Alexia Iasonos et al. STATISTICS IN MEDICINE
- Unknown
- (2016) JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Sex equality can explain the unique social structure of hunter-gatherer bands
- (2015) M. Dyble et al. SCIENCE
- Introducing the fit-criteria assessment plot – A visualisation tool to assist class enumeration in group-based trajectory modelling
- (2015) Sven L Klijn et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Unknown
- (2015) STATISTICS IN MEDICINE
- bcrm: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials
- (2015) Michael Sweeting et al. Journal of Statistical Software
- History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis
- (2014) C. Chao et al. ANNALS OF ONCOLOGY
- A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma In Situ of the Breast
- (2014) O. Lee et al. CLINICAL CANCER RESEARCH
- Evaluation of Statistical Designs in Phase I Expansion Cohorts: The Dana-Farber/Harvard Cancer Center Experience
- (2014) Suzanne E. Dahlberg et al. JNCI-Journal of the National Cancer Institute
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Small-sample behavior of novel phase I cancer trial designs
- (2013) Assaf P Oron et al. Clinical Trials
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Continual Reassessment Method for Partial Ordering
- (2011) Nolan A. Wages et al. BIOMETRICS
- Retrospective Robustness of the Continual Reassessment Method
- (2010) John O'Quigley et al. Journal of Biopharmaceutical Statistics
- Immune Regulation of Cancer
- (2010) Mary L. Disis JOURNAL OF CLINICAL ONCOLOGY
- The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints
- (2008) Matthias Mielke et al. STATISTICS IN MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started